Spotify has 188 million Premium users, but continues to lose money | Engadget

8

Spotify’s second-quarter financial release shows the streaming giant hasn’t yet felt the dread hand of the looming global recession. Unlike Netflix, which had to report a fall in its overall customer base, Spotify has seen both free and paying accounts grow. It now has 433 million users, up from the 422 million reported at the end of the first quarter. 188 million of those are paying for Premium, a leap of six million from three months ago, while a further four million are signed up on an ad-supported basis.

Despite industry-wide fears that household budgets would cut entertainment costs to help free up much-needed cash, Spotify has dodged cost-cutting so far. The company said that while it was keeping an eye on the “uncertain” environment, it was “pleased with the resilience of [its] business.” That said, the company did spend big to help grow its user figures, with marketing campaigns designed to coax back users who let their subscriptions lapse, or who wanted to expand to a family plan.

That marketing spend helped blow a hole in the company’s finances, with Spotify posting a quarterly loss of €194 million ($197 million). The company is banking on sharp increases in revenue both for subscriptions and advertising to help balance those losses out. In addition, its plan to pivot toward cheaper forms of audio content, like podcasts and audiobooks, should see the volume of cash it pays to record labels fall to a more tolerable (for Spotify) level — even if recording artists continue to demonstrate that they’re being starved of an income by the piddling royalties paid out on a per-stream basis.

All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.

Read More

Affiliate disclosure: The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products.

Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease.

LEAVE A REPLY

Please enter your comment!
Please enter your name here